United States · FDA National Drug Code directory

Azilect

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
68546-229_485881b0-fd51-4bea-8235-43efb940cd64
Product NDC
68546-229
Form
TABLET
Composition / generic term
Rasagiline mesylate
Labeler
Teva Neuroscience, Inc.
Marketing category
NDA
Marketing start / end (source format)
20060710
Source listing expiry
20271231

Source-listed ingredients

  • RASAGILINE MESYLATE — 1 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE (68546-229-56) · 68546-229-56

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Azilect — United States | Molindra Medicines